Mustang Bio (MBIO)
(Delayed Data from NSDQ)
$0.31 USD
-0.02 (-5.36%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.31 0.00 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for Mustang Bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 49 | 76 | 67 | 57 | 46 |
Income After Depreciation & Amortization | -49 | -76 | -67 | -57 | -46 |
Non-Operating Income | 2 | 2 | 0 | 1 | 1 |
Interest Expense | 4 | 3 | 0 | 4 | 2 |
Pretax Income | -52 | -78 | -66 | -60 | -46 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -52 | -78 | -66 | -60 | -46 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -52 | -78 | -66 | -60 | -46 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -47 | -76 | -64 | -53 | -44 |
Depreciation & Amortization (Cash Flow) | 2 | 0 | 2 | 4 | 2 |
Income After Depreciation & Amortization | -49 | -76 | -67 | -57 | -46 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.60 | 6.90 | 5.86 | 3.51 | 2.41 |
Diluted EPS Before Non-Recurring Items | -6.00 | -11.24 | -11.39 | -17.09 | -19.34 |
Diluted Net EPS (GAAP) | -6.00 | -11.24 | -11.39 | -17.09 | -19.34 |
Fiscal Year end for Mustang Bio, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.23 | 8.74 | 10.31 | 13.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.23 | -8.74 | -10.31 | -13.90 |
Non-Operating Income | NA | 0.04 | 0.12 | 0.25 | 0.59 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 2.93 |
Pretax Income | NA | -5.19 | -8.62 | -10.06 | -16.24 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.19 | -8.62 | -10.06 | -16.24 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.19 | -8.62 | -10.06 | -16.24 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 11.25 | 8.60 | 8.17 | 8.13 |
Diluted EPS Before Non-Recurring Items | NA | -0.46 | -0.71 | -1.23 | -2.00 |
Diluted Net EPS (GAAP) | NA | -0.46 | -0.71 | -1.23 | -2.00 |